(redirected from Bence Jones protein)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
BJPBharatiya Janata Party (India)
BJPBritish Journal of Photography
BJPBritish Journal of Pharmacology
BJPBritish Journal of Psychiatry
BJPBead Journal Project (visual journaling)
BJPBubble Jet Printer
BJPBence Jones Protein
BJPBulgarian Journal of Physics (Japan)
BJPBubble Jet Printer (Canon)
BJPBharat Jalao Party (India)
BJPBoston Jolly Pirates (band)
BJPBâtiment, Jardin, Piscine (French: Building, Garden, Pool)
BJPBulletin de Jurisprudence Pénale (French: Bulletin of Criminal Cases; Switzerland)
References in periodicals archive ?
Luke, "Effect of urinary pH and diatrizoate on Bence Jones protein nephrotoxicity in the rat," Kidney International, vol.
0 g/L) IgG[Kappa] peak and a small Bence Jones protein peak (16 mg/d) migrating in the same regions as originally noted.
No M protein, Bence Jones protein, accumulation of gallium, or abnormal cells in bone marrow were detected, which suggested that the plasmacytoma had not developed into multiple myeloma.
A systemic workup for multiple myeloma included a bone marrow biopsy, bone scan, quantitative immunoglobulin assay, and measurements of hematocrit, white blood cells, blood urea, serum creatinine, serum electrolytes, serum calcium, and Bence Jones proteins in urine.
These investigations included a complete blood cell count, measurement of serum calcium and creatinine levels, serum protein electrophoresis and immunoelectrophoresis, urinalysis for Bence Jones protein, evaluation of [[beta].
Findings on bone marrow biopsy were normal, as were the results of immunologic laboratory analysis, including an assay of Bence Jones proteins.
Our objectives, in a prospective study with consecutive samples received for SPEP, were to evaluate (a) whether the addition of serum FLCs identified extra patients with monoclonal gammopathies at the time of a first request for SPEP; (b) whether serum FLCs could replace urinalysis for Bence Jones protein (BJP); and (c) the cost and quality implications of routinely measuring serum FLCs.
The first laboratory test for a protein cancer marker, the Bence Jones protein in urine, was described in 1847.
Tests for Bence Jones protein in the urine and for serum myeloma protein were negative.